Surgical Treatment of Cavernous and Fibrous-Cavernous TB in Children
The Thoracic and Cardiovascular Surgeon · 01.01.2023 · 71 (01) · 67-72
DOI: 10.1055/s-0042-1754318 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.01.2023. Verfasst von Dmitry Borisovich Giller und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Phthisiopulmonology and Thoracic Surgery named after M.I. Perelman, I.M. Sechenov First Moscow State Medical University (Sechenov Unive…. Hauptthemen laut MEDLINE: Tuberculosis, Pulmonary, Tuberculosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Treatment of cavernous and fibrous cavernous tuberculosis in children, especially in the presence of multiple drug resistance-tuberculosis or extremely drug resistance-tuberculosis, presents a major challenge. Materials and Methods We analyzed results of treatment of 65 patients (mean age 14.8 + 2.9 years) with cavernous TB (group I) and 116 patients (mean age 15.6 + 1.9 years) with fibrous-cavernous TB (group II). Evaluation of treatment efficiency was performed directly at discharge and 1 year after treatment according to Lazerson's criteria.
Results
In group I, after 80 operations, two (2.5%) cases showed delayed expansion of the lung after combined resections, in group II, postoperative complications after 160 operations occurred in eight (5.0%) cases (the difference is reliable p ≤0,05). There was no hospital fatality. The effectiveness at the time of discharge from surgery (cessation of bacterization and elimination of decay cavities in the lung) was 100% in groups I and II, respectively. A year later, according to Lazerson's criteria, the efficiency in group I was 100%, in group II was 97.4%.
Conclusion
Operations in patients with cavernous tuberculosis performed after 10 to 12 months of conservative treatment present a lower risk of postoperative complications and relapses of cavernous tuberculosis than operations in patients with fibrous cavernous tuberculosis performed after 22 months or more of treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Phthisiopulmonology and Thoracic Surgery named after M.I. Perelman, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moskva, Russia.
ORCID-Profile: Ivan Ivanovich Martel
Zitieren
APA
Giller, D. B., Koroev, V. V., Kesaev, O. S., Enilenis, I. I., Dobrin, R. R., & Martel, I. I. (2023). Surgical Treatment of Cavernous and Fibrous-Cavernous TB in Children. The Thoracic and Cardiovascular Surgeon, 71(01), 67-72. https://doi.org/10.1055/s-0042-1754318
Vancouver
Giller DB, Koroev VV, Kesaev OS, Enilenis II, Dobrin RR, Martel II. Surgical Treatment of Cavernous and Fibrous-Cavernous TB in Children. The Thoracic and Cardiovascular Surgeon. 2023;71(01):67-72. doi:10.1055/s-0042-1754318
BibTeX
@article{Giller2023,
author = {Giller, Dmitry Borisovich and Koroev, Vadim Valerievich and Kesaev, Oleg Shamilievich and Enilenis, Inga Igorevna and Dobrin, Roman Romanovich and Martel, Ivan Ivanovich},
title = {Surgical Treatment of Cavernous and Fibrous-Cavernous TB in Children},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2023},
volume = {71},
number = {01},
pages = {67--72},
doi = {10.1055/s-0042-1754318}
}
EUVIMED